Low-dose, enteric-coated aspirin tablets reduced colorectal tumor recurrence in an Asian population, according to a study published in Gut.
Researchers analyzed 311 subjects with single/multiple colorectal adenomas and adenocarcinomas excised by endoscopy — of which 152 patients were treated with aspirin and 159 patients were placed in the placebo group.
The study found that the patients treated with aspirin displayed reduced colorectal tumourigenesis and primary endpoints as compared with the subjects in the placebo group. Also, in the aspirin-treated group, patients who were non-smokers — including those who had smoked in the past and who had never smoked — had a marked reduction in the number of recurrent tumors.
More articles on gastroenterology:
$66B Actavis-Allergan deal, Cantel Medical leadership appointment & more –5 recent GI/endoscopy company key notes
FDA clears Third Eye Panoramic device for colonoscopy
Can complementary & alternative medicine play a role in GI treatment?